Davidson Michael H. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$175,158.50
Insider Sells Quantity
1
Insider Sells Sum
$0

Insider Activity of Davidson Michael H.

According to the SEC Form 4 filings, Davidson Michael H., being in a position of

  1. Chief Executive Officer at NewAmsterdam Pharma Company N.V.,
    оver the last 12 months, has bought 10000 shares for $226,500, and sold 750000 shares for $25.33M,
    over all time since 2024-06-20, has bought 20000 shares for $394,159, and sold 773840 shares for $25.33M.

Biography of Davidson Michael H.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $226,500120
Sells
 $25,328,349480

Comparison of Insiders on Amount of Buys and Sells

2026-09-14PurchaseNewAmsterdam Pharma Company N.V.
NAMS
Chief Executive Officer
10,000
0.0082%
$22.65$226,500-3.87%
2026-03-02SaleNewAmsterdam Pharma Company N.V.
NAMS
Chief Executive Officer
443,707
0.3619%
$33.25$14.75M-9.08%
2026-02-26SaleNewAmsterdam Pharma Company N.V.
NAMS
Chief Executive Officer
183,332
0.1568%
$33.71$6.18M-12.89%
2026-02-25SaleNewAmsterdam Pharma Company N.V.
NAMS
Chief Executive Officer
58,253
0.0511%
$35.30$2.06M-14.71%
2026-02-24SaleNewAmsterdam Pharma Company N.V.
NAMS
Chief Executive Officer
64,708
0.0565%
$36.15$2.34M-17.08%
2026-01-07SaleNewAmsterdam Pharma Company N.V.
NAMS
Chief Executive Officer
11,582
–
$0$0-13.68%
2025-03-26SaleNewAmsterdam Pharma Company N.V.
NAMS
Chief Executive Officer
12,258
–
$0$0+19.9%
2024-08-20PurchaseNewAmsterdam Pharma Company N.V.
NAMS
Chief Executive Officer
5,000
0.0044%
$16.27$81,350+22%
2024-08-08PurchaseTenax Therapeutics, Inc.
TENX
director
2,500
0.1209%
$3.00$7,500+39.61%
2024-06-20PurchaseNewAmsterdam Pharma Company N.V.
NAMS
Chief Executive Officer
5,000
0.0047%
$17.26$86,309+11%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.